MOLN Molecular
- 8.580
- +2.205+34.59%
- 8.400
- -0.180-2.10%
Molecular News
Molecular | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Molecular | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Molecular | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Molecular | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Molecular | F-3: Registration statement for specified transactions by certain foreign private issuers
Molecular | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Molecular | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Analysis
Price Target
No Data
